SPRINGHILL Management Ltd, the fund manager for Spring Hill Biotech Ventures Sdn Bhd, Malaysia's first venture capital company for the biotech and pharmaceutical sectors, plans to further explore opportunities in the United States, European Union and Asian markets.
Springhill Management chairman Dr Kim Tan said the recent success of Spring Hill Biotech Ventures' investee company, India-based Glenmark Laboratories Ltd, in its reverse takeover of Mumbai Stock Exchange-listed Tasc Pharmaceuticals Ltd, marked the first initial public offering (IPO) entry under its portfolio of investee companies.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
